Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Adela, Inc
Mayo Clinic
Incyte Corporation
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
Cedars-Sinai Medical Center
Sanguine Biosciences
OHSU Knight Cancer Institute
Weprom
First Affiliated Hospital of Wenzhou Medical University
Shenzhen BinDeBio Ltd.
CureOne
Leaf Vertical Inc.
Celgene
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
SPGO Research Mannheim GmbH
M.D. Anderson Cancer Center
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca